NCT00239304View on ClinicalTrials.gov

Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

March 31, 2006

Conditions
Head and Neck Neoplasms
Interventions
DRUG

Gefitinib

DRUG

Cisplatin

PROCEDURE

Radiotherapy

Trial Locations (1)

Unknown

Research Centre, Helsinki

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY